PubMed

Predicting progression of Alzheimer's disease.

Doody RS, Pavlik V, Massman P, Rountree S, Darby E, Chan W.

Alzheimers Res Ther. 2010 Feb 23;2(1):2.PMID: 20178566 [PubMed - in process]Free PMC ArticleFree textRelated citations

A method for estimating progression rates in Alzheimer disease.

Doody RS, Massman P, Dunn JK.

Arch Neurol. 2001 Mar;58(3):449-54.PMID: 11255449 [PubMed - indexed for MEDLINE]Related citations

Donepezil for vascular cognitive impairment.

Malouf R, Birks J.

Cochrane Database Syst Rev. 2004;(1):CD004395. Review.PMID: 14974068 [PubMed - indexed for MEDLINE]Related citations

Persistent treatment with cholinesterase inhibitors and/or memantine slows clinical progression of Alzheimer disease.

Rountree SD, Chan W, Pavlik VN, Darby EJ, Siddiqui S, Doody RS.

Alzheimers Res Ther. 2009 Oct 21;1(2):7.PMID: 19845950 [PubMed]Free PMC ArticleFree textRelated citations

Selegiline for Alzheimer's disease.

Birks J, Flicker L.

Cochrane Database Syst Rev. 2003;(1):CD000442. Review.PMID: 12535396 [PubMed - indexed for MEDLINE]Related citations

Efficacy and safety of tarenflurbil in mild to moderate Alzheimer's disease: a randomised phase II trial.

Wilcock GK, Black SE, Hendrix SB, Zavitz KH, Swabb EA, Laughlin MA; Tarenflurbil Phase II Study investigators.

Lancet Neurol. 2008 Jun;7(6):483-93. Epub 2008 Apr 29. Erratum in: Lancet Neurol. 2008 Jul;7(7):575. PMID: 18450517 [PubMed - indexed for MEDLINE]Related citations

Clinical outcomes of possible versus probable Alzheimer's disease.

Villareal DT, Grant E, Miller JP, Storandt M, McKeel DW, Morris JC.

Neurology. 2003 Sep 9;61(5):661-7.PMID: 12963758 [PubMed - indexed for MEDLINE]Related citations

Transition from cognitively impaired not demented to Alzheimer's disease: an analysis of changes in functional abilities in a dementia clinic cohort.

Hsiung GY, Alipour S, Jacova C, Grand J, Gauthier S, Black SE, Bouchard RW, Kertesz A, Loy-English I, Hogan DB, Rockwood K, Feldman HH.

Dement Geriatr Cogn Disord. 2008;25(6):483-90. Epub 2008 Apr 16.PMID: 18417973 [PubMed - indexed for MEDLINE]Related citations

Memantine for dementia.

Areosa SA, Sherriff F.

Cochrane Database Syst Rev. 2003;(3):CD003154. Review. Update in: Cochrane Database Syst Rev. 2004;(4):CD003154. PMID: 12917950 [PubMed - indexed for MEDLINE]Related citations

Vascular disease and risk factors, rate of progression, and survival in Alzheimer's disease.

Bhargava D, Weiner MF, Hynan LS, Diaz-Arrastia R, Lipton AM.

J Geriatr Psychiatry Neurol. 2006 Jun;19(2):78-82.PMID: 16690992 [PubMed - indexed for MEDLINE]Related citations

Influence of premorbid IQ and education on progression of Alzheimer's disease.

Pavlik VN, Doody RS, Massman PJ, Chan W.

Dement Geriatr Cogn Disord. 2006;22(4):367-77. Epub 2006 Sep 5.PMID: 16954693 [PubMed - indexed for MEDLINE]Related citations

Apolipoprotein E epsilon4 allele is unrelated to cognitive or functional decline in Alzheimer's disease: retrospective and prospective analysis.

Kleiman T, Zdanys K, Black B, Rightmer T, Grey M, Garman K, Macavoy M, Gelernter J, van Dyck C.

Dement Geriatr Cogn Disord. 2006;22(1):73-82. Epub 2006 May 12.PMID: 16699282 [PubMed - indexed for MEDLINE]Related citations

Galantamine for Alzheimer's disease.

Olin J, Schneider L.

Cochrane Database Syst Rev. 2001;(4):CD001747. Review. Update in: Cochrane Database Syst Rev. 2002;(3):CD001747. PMID: 11687119 [PubMed - indexed for MEDLINE]Related citations

Efficacy of donepezil on maintenance of activities of daily living in patients with moderate to severe Alzheimer's disease and the effect on caregiver burden.

Feldman H, Gauthier S, Hecker J, Vellas B, Emir B, Mastey V, Subbiah P; Donepezil MSAD Study Investigators Group.

J Am Geriatr Soc. 2003 Jun;51(6):737-44. Erratum in: J Am Geriatr Soc. 2003 Sep;51(9):1331. PMID: 12757558 [PubMed - indexed for MEDLINE]Related citations

Efficacy of rivastigmine in Alzheimer's disease patients with rapid disease progression: results of a meta-analysis.

Farlow MR, Small GW, Quarg P, Krause A.

Dement Geriatr Cogn Disord. 2005;20(2-3):192-7. Epub 2005 Aug 3.PMID: 16088144 [PubMed - indexed for MEDLINE]Related citations

Metrifonate for Alzheimer's disease.

López-Arrieta JM, Schneider L.

Cochrane Database Syst Rev. 2006 Apr 19;(2):CD003155. Review.PMID: 16625573 [PubMed - indexed for MEDLINE]Related citations

Vitamin E for Alzheimer's disease and mild cognitive impairment.

Isaac MG, Quinn R, Tabet N.

Cochrane Database Syst Rev. 2008 Jul 16;(3):CD002854. Review.PMID: 18646084 [PubMed - indexed for MEDLINE]Related citations

Clinical prediction of Alzheimer disease dementia across the spectrum of mild cognitive impairment.

Dickerson BC, Sperling RA, Hyman BT, Albert MS, Blacker D.

Arch Gen Psychiatry. 2007 Dec;64(12):1443-50.PMID: 18056553 [PubMed - indexed for MEDLINE]Free PMC ArticleFree textRelated citations

The progression of cognitive deterioration and regional cerebral blood flow patterns in Alzheimer's disease: a longitudinal SPECT study.

Hanyu H, Sato T, Hirao K, Kanetaka H, Iwamoto T, Koizumi K.

J Neurol Sci. 2010 Mar 15;290(1-2):96-101. Epub 2009 Nov 20.PMID: 19931870 [PubMed - indexed for MEDLINE]Related citations

Comparison of different MRI brain atrophy rate measures with clinical disease progression in AD.

Jack CR Jr, Shiung MM, Gunter JL, O'Brien PC, Weigand SD, Knopman DS, Boeve BF, Ivnik RJ, Smith GE, Cha RH, Tangalos EG, Petersen RC.

Neurology. 2004 Feb 24;62(4):591-600.PMID: 14981176 [PubMed - indexed for MEDLINE]Free PMC ArticleFree textRelated citations